# Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE)

Study · id `cardio:ct-nct02798471` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02798471](<https://clinicaltrials.gov/study/NCT02798471>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT02798471

Browse, organ or system: Heart; Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 290 participants.

## Technical summary

Registry record NCT02798471. Randomized; single masking; primary purpose treatment. Start 2017-03-27 (actual); primary completion 2022-05-24 (actual). Results posted on 2023-03-06.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 290 participants (enrolled count; ClinicalTrials.gov record NCT02798471, source copy `cardio:ctgov-nct02798471-2025-02-28`, retrieved 2026-10-31)
- Started: 2017-03-27 (actual) (ClinicalTrials.gov record NCT02798471, source copy `cardio:ctgov-nct02798471-2025-02-28`, retrieved 2026-10-31)
- Primary completion: 2022-05-24 (actual) (ClinicalTrials.gov record NCT02798471, source copy `cardio:ctgov-nct02798471-2025-02-28`, retrieved 2026-10-31)
- Completion: 2022-05-24 (actual) (ClinicalTrials.gov record NCT02798471, source copy `cardio:ctgov-nct02798471-2025-02-28`, retrieved 2026-10-31)
- Results first posted: 2023-03-06 (ClinicalTrials.gov record NCT02798471, source copy `cardio:ctgov-nct02798471-2025-02-28`, retrieved 2026-10-31)
- Countries: United States; Argentina; Brazil; Bulgaria; Canada; Chile; Croatia; Czechia; Denmark; El Salvador; France; Germany; Guatemala; Hungary; India; Israel; Kenya; Lebanon; Malaysia; Netherlands; Norway; Panama; Portugal; Romania; Russia; Serbia; Singapore; Slovenia; South Korea; Spain; Taiwan; Thailand; Türkiye; Ukraine (ClinicalTrials.gov record NCT02798471, source copy `cardio:ctgov-nct02798471-2025-02-28`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02798471-2025-02-28`, retrieved 2026-10-31)

## The registry's words

- Brief title: Hokusai Study in Pediatric Patients With Confirmed Venous Thromboembolism (VTE)
- Condition: Venous Thromboembolism (VTE)
- Condition: Pulmonary Embolism
- Condition: Deep Vein Thrombosis (DVT)
- Intervention (Drug): Edoxaban
- Intervention (Drug): Standard of Care
- Lead sponsor: Daiichi Sankyo
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Deep vein thrombosis (`cardio:deep-vein-thrombosis`)
- Registry condition terms include this condition: Pulmonary embolism (`cardio:pulmonary-embolism`)
- Registry intervention name matches this record: Edoxaban (`cardio:edoxaban`)
- Registry lists this organization as the lead sponsor: Daiichi Sankyo (`cardio:org-daiichi-sankyo`)

## Provenance

Content hash: 201789c342ea56c66d370ed58943c9a7e3a49c5cf5e19fa4743cb2c9be0d0b22
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
